The link between TB and a gene mutation that causes lung cancer

Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease have not been extensively reported.

Research presented in the February 2012 issue of the International Association for the Study of Lung Cancer's shows a link between TB and mutations in the (EGFR), a type of found in non-small cell lung cancer. Researchers concluded that there is a relationship between pulmonary TB and EGFR mutations in patients with adenocarcinoma of the lungs. Adenocarcinoma is the most common type of lung cancer.

The researchers, including IALSC members Dr. Yuh-Min Chen, Dr. Reury-Perng Perng and Dr. Yu-Chin Lee, studied 275 patients with pulmonary adenocarcinoma between June 1999 and January 2011. Of those patients, 191 had EGFR mutations. Their findings show that "old TB lesions and scar cancer had a statistically significant association with EGFR mutation, especially exon 19 deletions," the most common type of EGFR tumor mutation.

The incidence of tumor EGFR mutations is found to be higher in East Asian countries, such as Taiwan, as is the prevalence of infection. The good news is that tumors with the EGFR mutation have a 75 percent response rate when treated with EGFR-tyrosine kinase inhibitors. This is likely why, according to the study, "those patients with old TB lesions who had EGFR mutations or exon 19 mutations survived longer than those who did not."

Provided by International Association for the Study of Lung Cancer

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Incomplete HPV vaccination may offer some protection

11 hours ago

Minority women who received the Human Papillomavirus Vaccination (HPV) even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. These findings appear in the journal ...

New imaging agent provides better picture of the gut

11 hours ago

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time ...

User comments